The drugs aim to remove aberrant protein clumps called amyloid plaques from the brains of Alzheimer's patients.

FORBES: Alzheimer's Drug Showdown

Denosumab is an antibody that blocks the RANK ligand, a protein that tells the body to remove bone.

FORBES: Amgen's Next Opponents